ABO-incompatible Living Donor Liver Transplantation With Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.

Kim, Jong Man

ABO-incompatible Living Donor Liver Transplantation With Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence. [electronic resource] - Transplantation 10 2018 - 1695-1701 p. digital

Publication Type: Comparative Study; Journal Article

1534-6080

10.1097/TP.0000000000002154 doi


ABO Blood-Group System--immunology
Adult
Aged
Allografts--immunology
Blood Group Incompatibility--immunology
Carcinoma, Hepatocellular--epidemiology
Disease-Free Survival
End Stage Liver Disease--surgery
Female
Graft Rejection--immunology
Humans
Isoantibodies--immunology
Liver--immunology
Liver Neoplasms--epidemiology
Liver Transplantation--adverse effects
Living Donors
Male
Middle Aged
Neoplasm Recurrence, Local--epidemiology
Plasma Exchange--adverse effects
Preoperative Care--adverse effects
Rituximab--adverse effects
Survival Rate
Young Adult